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ABSTRACT
Initiation of transcription in human mitochondria
involves two factors, TFAM and TFB2M, in addition
to the mitochondrial RNA polymerase, POLRMT. We
have investigated the organization of the human
mitochondrial transcription initiation complex on
the light-strand promoter (LSP) through solution
X-ray scattering, electron microscopy (EM) and
biochemical studies. Our EM results demonstrate a
compact organization of the initiation complex, sug-
gesting that protein–protein interactions might
help mediate initiation. We demonstrate that, in the
absence of DNA, only POLRMT and TFAM form a
stable interaction, albeit one with low affinity. This
is consistent with the expected transient nature of
the interactions necessary for initiation and implies
that the promoter DNA acts as a scaffold that
enables formation of the full initiation complex.
Docking of known crystal structures into our EM
maps results in a model for transcriptional initiation
that strongly correlates with new and existing bio-
chemical observations. Our results reveal the organ-
ization of TFAM, POLRMT and TFB2M around the
LSP and represent the first structural characteriza-
tion of the entire mitochondrial transcriptional initi-
ation complex.
INTRODUCTION
Mitochondria are responsible for many essential cellular
functions, including energy production through oxidative
phosphorylation, fatty acid oxidation, heme and phospho-
lipid biosynthesis, apoptosis and signal transduction (1–3).
Mitochondria harbor a small genome (16.5 kb in
mammals), encoding mitochondrial tRNAs, two rRNAs
and 13 components of the respiratory chain (4). Despite its
small size, expression of the mitochondrial genome is
critical for maintaining normal mitochondrial function.
Consistently, defects in mitochondrial gene expression
are associated with a myriad of genetic mitochondrial dis-
orders, age-related chronic diseases and the aging process
itself (5–7).
The first step in the process of gene expression is
transcription of the mitochondrial DNA (mtDNA). The
central component of the transcription machinery in
eukaryotes is the mitochondrial RNA polymerase
(POLRMT), believed to have originated from the T-odd
phage family as a result of an ancient phage-integration
event (8,9). POLRMTs have a conserved 80 kDa
C-terminal domain that shares significant structural
homology with their T-odd phage counterparts (10).
Despite this considerable homology, the mechanism of
mitochondrial transcription differs from that in T-odd
phages in some important aspects. For example, although
viral RNA polymerases can mediate all steps of transcrip-
tion, POLRMTs are unable to catalyze promoter-
dependent initiation without additional cofactors (11).
Accordingly, POLRMTs possess some unique structural
features not present in T-odd RNA polymerases (10). In
yeast and animals, POLRMTs contain a large divergent
N-terminal extension (NTE) of unclear function (12).
In human POLRMT, this NTE contains two
pentatricopeptide repeat domains that are believed to
possess nucleic acid binding ability (13,14) and have
been proposed to interact with the DNA substrate (10).
In yeast, deletion of the NTE leads to a loss of mitochon-
drial genome integrity (15) suggesting that the NTE might
mediate important interaction(s) between POLRMT, the
proteins responsible for RNA processing and translation,
(16) and the essential transcription factor Mtf1 (17,18).
Experiments with yeast POLRMT mutants that were par-
tially or fully devoid of the NTE demonstrated that it is
dispensable for processive RNA elongation, but does
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influence promoter-specific initiation, presumably by
modulating the interaction with Mtf1 (15). Moreover, it
was recently shown that deletion of the NTE in human
POLRMT similarly precludes promoter-dependent initi-
ation (10).
While in yeast only one cofactor, Mtf1, is required for
efficient promoter-dependent initiation of mitochondrial
transcription, metazoans require two cofactors: TFB2M
(homolog of Mtf1) and TFAM. TFB2M belongs to a
family of ribosomal RNA (rRNA) methyltransferases
(18,19) and in fact its paralog TFB1M is responsible for
an essential modification of the mitochondrial 12S rRNA
(20). Crosslinking studies have revealed that, at least in
humans, TFB2M interacts with the first incoming
ribonucleoside triphosphate, and along with POLRMT,
appears to participate in formation of the active site
where the initial steps of RNA primer synthesis are
catalyzed (21). Moreover, it has been reported that
POLRMT and TFB2M can be co-purified (22), further
implying that an interaction might exist between both
proteins.
TFAM is a high mobility group protein that serves two
functions in metazoans, playing a role in both transcrip-
tion initiation and nucleoid organization (23). The crystal
structure of TFAM reveals its ability to bend the
promoter DNA, implying that this unique property
might be important for transcription initiation (24,25).
In addition, a C-terminal tail in TFAM has been shown
to be essential for promoter-dependent initiation of tran-
scription, suggesting that this tail might mediate an im-
portant protein–protein or even protein–DNA interaction
(26–28).
Although TFAM is important for initiation in mamma-
lian mitochondria (29), the yeast ortholog of TFAM,
Abf2, does not play a role in activation of transcription
(18) and is only responsible for nucleoid packaging (30).
Interestingly, it has been reported that human
POLRMT, like its yeast homolog, retains some ability
to catalyze TFAM-independent initiation under certain
conditions (31). Moreover, TFAM-independent transcrip-
tion activity by POLRMT is critical for generating the
RNA primers needed for lagging strand synthesis during
mtDNA replication (32)
Despite the substantial understanding of the transcrip-
tion initiation process we have gained to date, certain key
questions remain unanswered. For instance, the specific
protein–DNA and protein–protein interactions that
govern and regulate the initiation process are still not
well understood. Furthermore, current models for the or-
ganization of the transcription initiation complex are
based on indirect observations and the overall structure
of the initiation complex remains unknown. Here, we
present a study of the protein–protein interactions that
take place during the initiation process, combined with a
structural characterization of the initiation complex based
on single-particle electron microscopy (EM) reconstruc-
tions and solution X-ray scattering analysis. Our results
comprise, to our knowledge, the first direct structural
characterization of the architecture of the mitochondrial
transcription initiation complex.
MATERIALS AND METHODS
Protein expression and purification
Human TFAM (UniProt Q00059; residues 43–246),
TFB2M (UniProt Q9H5Q4; residues 20–396) and
POLRMT (UniProt O00411; residues 42–1230) were ex-
pressed as fusions with his-tagged maltose binding protein
and purified as described (33). The POLRMT N-terminal
extension (NTE) deletion mutant in which the whole
N-terminal domain (residues 1–339) has been eliminated
(POLRMTNTE; Supplementary Figure S1A) and the
TFAM C-terminal extension (CTE) deletion mutant
(TFAMCTE; residues 43–226; Supplementary Figure
S1B) were cloned into pTEV-HMBP3 and over-expressed
in Arctic Xpress Escherichia coli (DE3) cells (Stratagene)
at 16C for 20 h. TFAM and TFB2M were purified using
ProBond Resin (Invitrogen), followed by overnight
tobacco etch virus (TEV) protease cleavage, Heparin,
Mono S and size-exclusion chromatography. POLRMT
was purified by Heparin chromatography, overnight
TEV protease cleavage, followed by a second Heparin,
Mono S and size-exclusion chromatography. Proteins
were concentrated using a 10 000 MWCO Amicon Ultra-
15 device. Concentrated proteins were stored in 20mM
HEPES (pH 8.0), 200mM KCl, 5% glycerol and 1mM
DTT. All proteins used in this study correspond to the
mature form and were cloned without the mitochondrial
localization sequence, which was experimentally deter-
mined for TFAM (34), predicted with MitoProt (35) for
POLRMT and predicted with TargetP (36) for TFB2M.
The proteins that were used in the reconstruction of the
mitochondrial transcription machinery were 95–99% pure
(Supplementary Figure S1C).
Transcription assay
For promoter-dependent transcription, nucleotides
171–470 of the human mitochondrial DNA (containing
the light-strand promoter) were cloned between the NcoI
and HindIII sites of pET-22 (Novagen). The substrate was
linearized using HindIII. Reactions were carried out in
20 ml and contained 30 ng DNA, 20mM HEPES (pH
8.0), 5% glycerol, 10mM MgCl2, 150mM KCl, 1mM
DTT, 100 mg/ml BSA, 0.4mM ATP, 0.15mM CTP
and GTP, 0.01mM UTP and 1 ml of [a-32P]UTP.
Transcription was initiated by addition of 400 fmol
POLRMT or POLRMTNTE, 500 fmol TFB2M and
2.5 pmol TFAM. Reactions were incubated for 30min at
32C and stopped by adding 100 ml of 1% SDS, 20mM
EDTA, 300mM NaAc, 20 mg Calf Thymus DNA and
0.12mg/ml glycogen. Products were phenol extracted,
ethanol precipitated, resuspended in 20 ml of loading
buffer and analyzed by polyacrylamide gel electrophoresis
(PAGE) (Supplementary Figure S1D).
To confirm that our POLRMTNTE mutant is stable,
we have analyzed its activity using a simple polymeriza-
tion assay in which the polymerase is faced with a tailed
substrate. This assay mimics elongation conditions in
which the polymerase is synthesizing the nascent RNA
chain while melting and displacing the DNA hybrid.
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Both POLRMTNTE and full-length POLRMT were
active in this assay (Supplementary Figure S1E).
Pull-down assays
POLRMT, POLRMTNTE, TFAM or TFAMCTE were
covalently immobilized into NHS-activated Agarose resin
(Thermo Scientific) following the manufacturer’s recom-
mendations. The coupling reaction was performed on
50 ml of resin with 50 ml 1mg/ml protein in an amine-free
buffer (20mM HEPES pH 8.0, 5% glycerol, 150mM KCl,
1mM DTT) for 4 h at 4C. Following immobilization, the
remaining sites were blocked with aminoethanol. The
resin was subsequently washed and incubated with a
1mg/ml solution of each protein. After 1-h incubation at
4C, the resin was washed and eluted with 0.2M glycine-
HCl (pH 2.5–3.0). Fractions were analyzed by SDS gel
electrophoresis. To account for non-specific binding, the
same amount of deactivated resin without immobilized
protein was used as a control.
Isothermal titration calorimetry (ITC) experiments
Experiments were performed with a VP-ITC calorimeter
(Microcal) at 25C with a mixing speed of 302 rpm.
POLRMT (70mM) or POLRMTNTE (75mM) proteins in
the sample cell were titrated with 5 -ml injections (first injec-
tion 2ml) of 0.7mM TFAM, TFAMCTE or TFB2M.
Samples were prepared by dialyzing all interacting compo-
nents extensively against a buffer containing 20mM HEPES
(pH 8.0), 200mM KCl, 5% glycerol and 1mM EDTA. The
heats of dilution of both proteins with buffer were
determined and subtracted prior to analysis. Data were
analyzed using the ORIGIN software supplied with the in-
strument according to the one- and two-binding site models.
Size-exclusion chromatography
10 mM POLRMT or POLRMTNTE were pre-mixed with
20 mM TFB2M in the absence of DNA or in presence of
the LSP27 oligonucleotide (10 mM). LSP27 was made by
annealing LSP27-1 (50-CAA ATT TTA TCT TTT GGC
GGT ATG CAC-30) and LSP27-2 (50-GTG CAT ACC
GCC AAA AGA TAA AAT TTG-30). A Sephadex 200
10/300 gel-filtration column was used for analytical gel-
filtration analysis of the samples. Fractions were analyzed
by SDS gel electrophoresis.
SAXS/WAXS measurements
TFB2M samples were prepared in 20mM HEPES (pH
8.0), 200mM KCl, 5% glycerol and 1mM DTT within
24 h of data acquisition and were stored at 4C.
Scattering data were collected at beamline X9 of the
National Synchrotron Light Source (NSLS, Upton, New
York) using a Pilatus 300K located 3.4m from the sample
for small angle X-ray data. Wide-angle X-ray scattering
data were collected simultaneously with SAXS data using
a Photonic Science CCD located 0.47m from the sample.
About 20 ml of sample were continuously flowed through a
1mm diameter capillary and exposed to a 400 200 mm
X-ray beam with a wavelength of 0.9184 Å for 30 s of total
measurement time. Scattering data for TFB2M were
collected at concentrations of 2.5, 5, and 10mg/ml in trip-
licate. Normalization for beam intensity, buffer subtrac-
tion and merging of data from both detectors were carried
out using PRIMUS (37). The radius of gyration (Rg) was
calculated using a Guinier approximation, I(q)= I(0)
exp(q2Rg
2/3), where a plot of I(q) and q2 is linear for
q< 1.3/Rg (38). Six independent scattering trials were
averaged. GNOM was used to determine the pair distri-
bution function, P(r) and maximum particle dimension,
Dmax (39). The linearity of the Guinier region and the
forward scattering intensity were used to validate that
the TFB2M samples were monodisperse in solution. The
forward scattering intensity, I(0), is the theoretical scat-
tering at a q-value of 0 and is proportional to the molecu-
lar weight of the sample (40). I(0)/c, where c is
concentration, was identical for all TFB2M measure-
ments. About 10 independent ab initio beads models that
describe the experimental data were calculated using
DAMMIF (41). The resulting models, which had an
average 2 of 1.65±0.06, were subsequently aligned,
averaged and filtered using DAMAVER (42).
EM analysis
POLRMT alone was adsorbed to glow discharged carbon-
coated copper grids at 1 mM concentration and stained
with 1% (w/v) uranyl acetate. To reconstruct a mitochon-
drial transcription initiation complex, POLRMT, TFB2M
and TFAM were mixed in a 1:1 molar ratio at a concen-
tration of 7 mM in the presence of 45-bp double-stranded
substrate containing the mitochondrial light-strand
promoter (LSP) and TFAM-binding site (coding strand:
30-AAT CAA CCC CCC ACT GAC AAT TTT CAC
GTA TGG CGG TTT TCT ATT-50) and ATP and
diluted to 0.5 mM with binding buffer (20mM HEPES
pH 8.0, 150mM KCl, 1mM EDTA, 10mM MgCl2 and
5mM DTT). Immediately after dilution, 3 ml aliquots of
protein were applied onto 300-mesh copper grids (Ted
Pella) that were coated with carbon film and glow-
discharged for 10 s. After 1min, the protein solution was
blotted with filter paper and stained with 1% (w/v) uranyl
acetate solution.
The grids with non-promoter DNA (coding strand:
30-CTA GCC ATG CCA CTG GCT CTT AGA TAA
CCC TAT ACA GTG ATT ATG-50) and the three full-
length proteins (type A control grids) and the grids with
the LSP promoter DNA, full-length polRMT, TFB2M
and C-terminally truncated TFAM (TFAMCTE) were
prepared according to the same procedure (Supplementary
Figure S2).
Grids were inspected on a Tecnai F20 operated at
200 kV with a 4 k 4 k Tietz CCD camera. Images were
acquired at a magnification of 88 249 corresponding to
3.4 Å/pixel. All image processing and reconstructions steps
were carried out using EMAN (43). Briefly, 3764 particles
(for POLRMT apoenzyme) and 12 453 (for the full initi-
ation complex) were selected, the contrast transfer
function (ctf) of the images was determined and the
phases flipped accordingly and an initial model was
generated from reference-free class-averages and used
for reference-based alignment. For the reconstruction of
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the mitochondrial initiation complex, a set of 12 453
raw images was subjected to reference-free alignment.
Reference-free classes were divided into two subsets
based on particle size and two initial models were
generated from each subset. One model had a visibly
elongated shape, whereas the other was more compact.
We utilized both models as starting points for parallel re-
finement, as implemented in EMAN’s MULTIREFINE
routine (43). In addition, a smaller size nearly spherical
blob of 70 Å diameter was generated as a third model.
The latter model was used as a potential scavenger of
smaller size fragments. The procedure of parallel refine-
ment yielded three models; two of them showed only
minor differences. The size and shape of both models
roughly corresponded to POLRMT. A third model was
a good candidate for the quaternary initiation complex
(POLRMT:TFAM:TFB2:DNA) and was subsequently
used for reconstruction of the initiation complex (see
below). The raw images were distributed approximately
evenly between the first two models and the third one
(2875, 3048 and 6530, accordingly). Based on that, we
conclude the initiation complex was 50% dissociated
before or during grid preparation. Smaller fragments
(TFB2M and TFAM) were not detected after reference-
free alignment/refinement, probably because the corres-
ponding raw images were poorly visible on the grids, so
they were ignored during particle picking.
The particle images that grouped with the third model
(i.e. the putative initiation complex model) were combined
in a separate set and used for further structure refinement,
which provided an additional improvement of the EM
model (Supplementary Figure S3). To estimate the reso-
lution of the final structure, two structures were calculated
on the basis of even or odd halves of the final class
set using the EOTEST routine. According to the Fourier
shell correlation (FSC) (Figure 1C) curve at a 0.5 thresh-
old value, the resolution of the final structures was 25 Å.
The volumes for surface rendering were calculated using a
known standard protein density of 0.81Da/Å2 and mo-
lecular mass of 206 kDa (for the initiation complex).
Docking
For the POLRMT map, the crystal structure of POLRMT
(PDB accession number 3SPA) was positioned as a rigid
body automatically using SITUS (44) and our in-house
fast Fourier transform (FFT)-based software (45) for
systematic search.
For the full initiation complex, we extended our system-
atic global search protein docking approach (45) for its
application to docking of proteins (PDB accession
numbers 3SPA, 4GC5 and 3TQ6) into electron density
maps. We followed a two-step algorithm: (i) For a given
protein, billions of docked conformations were sampled
by soft rigid body docking based on a FFT correlation
approach (45). The method performs exhaustive evalu-
ation of correlations in the discretized 6D space of
mutual orientations of the density map and the protein.
The center of the EM density map (or its segment) was
fixed at the origin of the coordinate system. The transla-
tional space was represented as a grid of 2 Å displacements
of the protein center of mass, and the rotational space
was quasi-uniformly sampled using 50 000 rotations (45).
Correlation was calculated between smoothed EM density
grid and the smoothed grid of atomic volumes of the pro-
tein (45). (ii) The highest scoring solutions were clustered
for redundancy using a simple greedy clustering algo-
rithm. The lowest correlation score solution was
reported and all the neighboring solutions within 10 Å
root-mean-square deviation (RMSD) were assigned to
the same cluster. The members of this cluster were
removed and the next lowest correlation structure is
selected as the seed of the next cluster. The process is
repeated until the desired number of clusters is reported
or the current cluster correlation score falls <30% of the
top scoring solution.
RESULTS
EM reconstruction of the transcription initiation complex
reveals a bi-lobed arrangement
Although the recently solved crystal structures of TFAM
and POLRMT have provided significant structural insight
into the protein–DNA interactions relevant to transcrip-
tion initiation (24,25,46) no structural information exists
regarding the organization of the initiation complex as a
whole. In an attempt to expand our understanding of the
overall architecture of the initiation complex and the func-
tional implications of the protein–protein and protein–
DNA interactions relevant for transcription, we have
carried out a single-particle EM reconstruction of the
full initiation complex. Considering the likely importance
of the promoter DNA for the stability of the initiation
complex, we decided to conduct our reconstruction by
combining full-length POLRMT, TFB2M and TFAM
with a 45-bp DNA oligonucleotide containing both the
mitochondrial LSP and TFAM-binding site, in conditions
that mimic those used for initiation assays in vitro (see
‘Materials and Methods’ section). In addition to that,
two sets of control grids were prepared. The type A
control grids were prepared with the DNA fragment con-
taining no promoter sequence and the three full-length
proteins (Supplementary Figures S1A and S2A). The
type B grids contained the LSP promoter DNA, full-
length polRMT, TFB2M and C-terminally truncated
TFAM (TFAMCTE; Supplementary Figures S1B
and S2B)
The EM images of the grids containing the initiation
complex (Figure 1A; Supplementary Figure S2C and E)
contained a considerable amount of particles having a
bi-lobal shape whose size roughly corresponded to the
expected size of the quaternary initiation complex. In
addition to that, smaller particles (probably individual
components of the initiation complex, including
POLRMT) were also observed on the grids, which
implied partial dissociation of the initiation complex
during or before grid preparation. In contrast, the
control A grids contained particles that were highly
diverse in size and shape, probably as a result of
random aggregation of initiation complex components in
the absence of the promoter DNA sequence. The
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appearance of the control B grids more closely resembled
that of the initiation complex grids (Figure 1A and
Supplementary Figure S2C). However, reference-free
alignment of the particles collected from those grids
revealed an almost total absence of well-organized larger
size particles (Supplementary Figure S2D). Smaller par-
ticles having a compact round shape were observed
instead. Taken together, these data confirm the import-
ance of the promoter-containing DNA for assembly of
the initiation complex as well as the role the C-terminus
of TFAM plays in the assembly of the initiation complex
at LSP. We can conclude, therefore, that the particles
observed on the initiation complex grids belonged, most
likely, to the initiation complex, not to a simple quater-
nary complex of POLRMT, TFB2M and TFAM non-
specifically bound to the DNA molecule.
As a considerable amount of smaller size particles was
observed on the initiation complex grids (Figure 1A), the
concern arose that those particles could adversely affect
our 3D model reconstruction. Therefore, instead of a
simple refinement procedure, we decided to utilize a
multirefinement protocol for the 3D reconstruction, as
implemented in the MULTIREFINE routine of the
EMAN package (43). Briefly, three initial models were
generated as described in the ‘Materials and Methods’
section, and they were subjected to iterative refinement
using the entire image set. During this procedure, each
image from the set is used for only one model (out
of three). As a rule, when the image set belongs to a struc-
turally homogeneous particle (in other words, different
size images correspond to different particle orientations,
not to different size particles), all models converge to a
similar structure. In our case, however, only the first and
the second models converged (Supplementary Figure S3)
to a compact round shaped structure, whereas the third
model produced a larger, elongated bi-lobal shape. As
6530 (out of 12 453) images corresponded to the latter
structure, we concluded that about half of the initiation
complex existed in a dissociated from (perhaps resulting
from grid preparation). Taking into account that the con-
centration of the initiation complex in the solution applied
to the grids was 0.1mM, such a degree of dissociation is
quite reasonable; the complex cannot be highly stable,
because such high stability would likely prevent the
required transition from initiation to elongation mode.
Further refinement using the 6530 image set, which was
separated from the initial raw image set, yielded a final
model whose re-projections satisfactorily matched repre-
sentative reference-free class averages (Figure 1B). The
final reconstruction was based on 6530 particles and
resulted in a 25 Å resolution model of the quaternary
POLRMT:TFB2M:TFAM:DNA complex (Figure 1C).
Figure 1. EM reconstruction of the mitochondrial transcription initiation complex. (A) Representative raw micrograph of uranyl-stained grids
containing a quaternary POLRMT:TFB2M:TFAM:DNA complex. (B) Representative reference-free class averages (top row) and corresponding
re-projections of the final model (bottom row). (C) The final resolution was estimated as 25 Å using the Fourier shell correlation criterion with a
cutoff of 0.5. (D) Euler angle distribution plot of POLRMT:TFB2M:TFAM particle projections by the end of the refinement procedure. (E) The final
structure of the mitochondrial transcription initiation complex shown in 90 rotations.
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The EM map of the initiation complex had a distorted bi-
lobed shape with dimensions 140 110 85 Å (Figure
1E). Brief inspection of the envelope demonstrated that
its volume and shape allows accommodation of all three
proteins from the transcription initiation complex and its
compact shape implies that interactions are likely to take
place between the three protein components of the
complex. Given the functional role of this complex,
these interactions are likely to be transient.
POLRMT physically interacts with TFAM
After considering the shape of our EM envelope and the
likelihood of protein–protein interactions within the initi-
ation complex at LSP, we decided to probe the nature of the
putative interactions within the transcription initiation
complex. We performed a pull-down assay using purified
un-tagged proteins (see ‘Materials and Methods’ section).
First, we covalently immobilized TFAM on N-hydroxy-
succinimide (NHS)-activated agarose and used this resin
to probe all possible interactions between POLRMT,
TBF2M and TFAM. As a control for non-specific
binding to the resin, inactivated resin without immobilized
protein was used. The only clear evidence of an interaction
that was observed corresponded to full-length POLRMT
and full-length TFAM (Figure 2A and C).
In order to further confirm this observation, we per-
formed the reverse experiment by covalently immobilizing
full-length POLRMT onto the resin. We then probed
for interactions with TFAM and TFB2M. As shown in
Figure 2B, the result clearly suggests the existence of a
stable interaction between POLRMT and TFAM.
However, no evidence of a direct interaction between
POLRMT and TFB2M or between TFB2M and TFAM
was observed under our experimental conditions.
The POLRMT–TFAM interaction is of low affinity and
depends on the NTE of POLRMT and the C-terminal
tail of TFAM
To further investigate the nature of the TFAM–POLRMT
interaction we decided to use isothermal titration calorim-
etry (ITC) to quantitatively characterize the binding
equilibrium. ITC measurements demonstrate a clear exo-
thermic (H = 11.1 kcal/mol) interaction between
POLRMT and TFAM (KD=4.6 mM; Figure 3A). This
interaction is also characterized by moderately negative
binding entropy (S=11.4 cal/mol·K), suggesting that
stabilization of the POLRMT–TFAM complex has pre-
dominantly an enthalpic, not entropic nature. We next
decided to probe which regions in POLRMT and TFAM
might be responsible for this interaction. The non-
conserved NTE of POLRMT was an obvious candidate,
and consistent with the pull-down results (Figure 2), titra-
tion of a NTEmutant of POLRMT exhibited no thermal
effect in the ITC experiments (Figure 3B), suggesting that
the binary interaction between TFAM and POLRMT is
mediated by the NTE. Similarly, we decided to also
examine the importance of the C-terminal domain of
TFAM (CTE) for this interaction. Like the NTE of
POLRMT, the CTE of TFAM is known to be essential
for transcription initiation and it does not appear to
directly interact with DNA in the TFAM crystal structure.
Once again, consistent with pull-down experiments (Figure
2), ITC results using TFAMCTE suggest that the C-
terminal domain of TFAM plays an essential role in
mediating the TFAM–POLRMT interaction (Figure 3C).
POLRMT and TFB2M do not form a stable complex in
the absence of promoter DNA
Given that POLRMT and TFB2M can be co-purified (22),
we hypothesized that stable association of the initiation
complex with the promoter would require an interaction
between POLRMT and TFB2M. Surprisingly, we
were not able to observe any evidence of an interaction be-
tween these proteins in pull-down experiments (Figure 2).
However, this approach might not be sufficiently sensitive
for low-affinity interactions. Thus, we decided to analyze
the putative association between POLRMT and TFB2M
using isothermal calorimetry. Titration of POLRMT
with TFB2M resulted in no appreciable thermal effect
(Supplementary Figure S4). Although it cannot be
excluded that the thermal effect is too small to be
detected, together with the results of the pull-down experi-
ments these results suggest that the two proteins do not
directly bind to one another. Given that POLRMT and
TFB2M can mediate TFAM-independent initiation and
both proteins can be co-purified under some conditions,
we speculated that a stable complex might nevertheless
form in the presence of promoter DNA. We used gel-
filtration chromatography to test this hypothesis and
found that the peaks corresponding to POLRMT and
TFB2M can be fully resolved on a Sephadex 200 10/300
gel-filtration column (Figure 4A and Supplementary
Figure S5). In contrast, a similar experiment performed
in the presence of a linear promoter DNA substrate
(LSP27, see ‘Materials and Methods’ section)
demonstrated that the initial fractions (corresponding to
the high molecular weight species) now contained both
POLRMT and TFB2M (Figure 4C). Our results suggest
that whereas POLRMT and TFB2M do not interact
strongly with each other in the absence of promoter
DNA, in the presence of the promoter they can form a
stable POLRMT:TFB2M:DNA ternary complex.
Interestingly, in this case the NTE of POLRMT is dispens-
able for the interaction (Figure 4B and D), suggesting that
the observed ternary complex only depends on the
presence of the C-terminal region of POLRMT. It is im-
portant to note that this approach does not allow us to
determine whether this interaction is specific and to which
degree it is relevant to transcription initiation.
Single-particle reconstruction of POLRMT
We next decided to generate a docking model of the initi-
ation complex based on our EM map. The N-terminal
domain of POLRMT was not resolved in the electron
density of the recent crystal structure of the enzyme, pre-
sumably due to significant flexibility or disorder (10).
Thus, in an attempt to obtain a full-length structural char-
acterization of POLRMT and facilitate docking into our
EM envelope, we decided to perform a model-independent
EM single-particle reconstruction of POLRMT.
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Furthermore, we reasoned that this determination might
allow us to obtain a confident assignment of the position
of POLRMT within the complex. We analyzed 3764
images of POLRMT preserved in 1% uranyl acetate
stain and reconstructed its 3D structure using reference-
free alignment and common-line Euler angle assignment
(see ‘Materials and Methods’ section), followed by itera-
tive projection matching refinement of the initial model as
implemented in the EMAN software package. The struc-
ture we obtained after 12 cycles of refinement has
an elongated globular shape and displays a robust fit
(cross-correlation coefficient 0.86) with the existing
X-Ray structure of POLRMT (Figure 5A). Manual and
computer-aided (SITUS and our in-house FFT-based
search software; see ‘Materials and Methods’ section)
docking of POLRMT (PDB: 3SPA) resulted in identical
docking orientations. Consistent with the previously pub-
lished crystallographic results, it is clear that the
N-terminal domain of POLRMT is also disordered in
the EM structure, providing further evidence for its flexi-
bility, at least in the absence of promoter DNA.
TFB2M is structurally homologous to TFB1M
The only component of the initiation complex for which
there is no known structure is the TFB2M transcription
factor. However, a structure of its mouse paralog TFB1M,
(18% identity) has recently been solved (47). TFB2M and
TFB1M are thought to share a common methyltransferase
core domain, but TFB2M contains a larger N-terminal tail
whose function is not yet known, but that appears to
be dispensable for transcription initiation (21). Thus, we
decided to assess whether the TFB1M structure would be
an appropriate model for TFB2M to be used for docking
into our EM envelope. Given the relatively small size of
TFB2M (45 kD), we decided to carry out small- and wide-
angle X-ray scattering experiments in order to obtain its
overall structure and further characterize the shape of this
protein.
The SAXS/WAXS data show that human TFB2M has
a slightly larger maximal dimension (Dmax) compared to
mouse TFB1M, at 109±3 Å versus 90±5 Å, respectively
(Supplementary Figure S6; for mmTFB1M, the Dmax was
determined from the crystal structure), which is consistent
with the presence of a larger N-terminal tail in hsTFB2M.
Consistently, the experimental pairwise-distance distribu-
tion [P(r)] function for human TFB2M is relatively
skewed, suggesting an elongated asymmetric shape with
the bulk mass of the protein having dimensions
75 35 Å2.
The SAXS/WAXS data were used to generate low-
resolution ab initio models of 3D arrangements of
Figure 2. POLRMT physically interacts with TFAM. (A) Pull-down
assay to analyze interactions with purified untagged TFAM or
TFAMCTE. The proteins were covalently bound to NHS-activated
agarose and incubated with POLRMT, TFB2M or POLRMTNTE to
test for the presence of a direct physical interaction. As a control for
non-specific binding to the resin, inactivated resin without immobilized
protein was used. Compared with the control, the only clear interaction
observed was between full-length POLRMT and full-length TFAM.
(B) A reverse experiment performed by covalently immobilizing full-
length POLRMT or POLRMTNTE onto the resin. We then probed for
interactions with TFB2M, TFAM and TFAMCTE. The result further
suggests the existence of an interaction between POLRMT and TFAM.
However, no evidence was found of a direct interaction between
POLRMT and TFB2M or between TFB2M and TFAM.
(C) Quantification of the results shown in panels A and B. The
Precision Plus Protein Dual Color Standard protein marker (BioRad)
Figure 2. Continued
shown in panels A and B (indicated with the letter M) contains the
following bands: 250 kDa, 150 kDa, 100 kDa, 75 kDa, 50 kDa, 37 kDa
and 25 kDa. A control lane in panels A and B is indicated with the
letter C and the predicted molecular masses (based on sequence) for the
proteins are as follows: 134.5 kDa for POLRMT, 101 kDa for
POLRMTNTE, 24.4 kDa for TFAM, 21.9 kDa for TFAMCTE and
43.3 kDa for TFB2M.
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scattering centers, or beads that provide the shape of the
molecular envelope for human TFB2M (see ‘Materials
and Methods’ section). A molecular surface representation
of the resulting filtered average bead model for human
TFB2M is shown in Figure 5B, and the overall shape is
a deformed prolate ellipsoid with a narrower extended tail.
The wider section has dimensions that closely resemble
those of mouse TFB1M (75 35 Å2). The remaining
volume is consistent with the larger N-terminal tail of
TFB2M. A theoretical scattering profile was calculated
using the mouse TFB1M crystal structure (47,48) and
compared directly with the experimental scattering data
for human TFB2M, resulting in a robust fit that further
supports the structural similarity of these two proteins and
conservation of the methyltransferase fold (Figure 5C).
Docking model of the transcription initiation complex
The volume of the EM envelope for the initiation complex
is consistent with the expected volume from the individual
structures of each component. Comparison of the EM
map for POLRMT and the TFB2M SAXS/WAXS
envelope with the EM map of the full initiation complex
allows for preliminary localization of the individual com-
ponents. The majority of volume in the larger lobe corres-
ponds to POLRMT, whereas the remaining space
accommodates TFB2M (Figure 5D). The size and shape
of the smaller lobe corresponds to the expected volume for
TFAM (Figure 5E).
Importantly, a wealth of biochemical information exists
pertaining to certain aspects of the organization of the
complex, including details of specific protein–protein and
protein–DNA interactions (49,50). In addition, both the
initiation site and TFAM-binding sites have been clearly
defined, (51) and together, these details provide an
Figure 3. The interaction between POLRMT and TFAM is dependent on the NTE. (A) Isothermal titration calorimetry experiments of TFAM-
binding to POLRMT (B) TFAM-binding to POLRMTNTE or (C) TFAMCTE binding to POLRMT performed at 25C. In all three cases, the top
panel represents the heat signal for injections of TFAM or TFAMCTE into the calorimeter cell containing POLRMT or POLRMTNTE. The
bottom panel displays the integrated heat for each injection after peak integration and subtraction of basal values fitted to a simple single-site binding
model (solid line). The stoichiometry (N) and binding constant (KD) for the interaction between TFAM and POLRMT are shown in the bottom
panel. No thermal effect was observed for the putative interaction between TFAM and POLRMTNTE, or between TFAMCTE and POLRMT.
Figure 4. POLRMT and TFB2M interact in a DNA-dependent
manner. Gel-filtration experiment demonstrating that both proteins
could be resolved as separate peaks on a Sephadex 200 10/300 gel
filtration column in the absence of promoter DNA (A) and (B).
However, when linear promoter DNA was included in the experiment,
both POLRMT and POLRMTNTE co-eluted with TFB2M, suggesting
that a stable POLRMT:TFB2M complex is formed in the presence of
promoter DNA (C) and (D). Actual size-exclusion chromatograms
for experiments without the promoter DNA (E) and with promoter
DNA (F).
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important set of biochemical constraints that should be
recapitulated by a valid docking model. We thus set out
to reconcile all existing information, including our EM
results, into a final model for the quaternary complex.
We proceeded by docking each individual component
into their corresponding segments, while retaining
multiple suboptimal solutions as described in methods
(see ‘Materials and Methods’ section). We then selected
the best scoring model that satisfied all structural and
biochemical constraints, while avoiding significant inter-
component clashes.
The final model (Figure 6) suggests that the organiza-
tion of the initiation complex is more compact than ini-
tially expected (21,50). Both POLRMT and TFB2M
occupy the larger lobe in the EM envelope, but they asso-
ciate with opposite sides of the open promoter around the
initiation site. Consistent with the absence of a strong
interaction, they do not establish extensive protein–
protein contacts. TFAM is bound to its binding site
upstream of the initiation site and does not appear to
establish extensive contacts with any of the other two
proteins, but its C-terminal tail is located in close proxim-
ity to the N-terminal end of POLRMT, which is in agree-
ment with our biochemical observations. Interestingly,
although our EM structure of POLRMT exhibits the
same disorder in the N-terminus seen in the POLRMT
crystal structure, in the quaternary complex additional
density in the map is apparent (indicated with an
asterisk in Figures 5E and 6). The additional density
appears to correspond to the N-terminus of POLRMT,
implying that this domain becomes well ordered in the
context of a fully assembled initiation complex.
Additional density was also observed adjacent to the
expected location of the upstream duplex between
POLRMT/TFB2M and TFAM. This density likely corres-
ponds to the large N-terminal tail of TFB2M that is also
observed in the SAXS/WAXS analysis. Based on struc-
tural predictions, this tail might contact the upstream
duplex, consistent with previous observations (21). It is
important to note that DNA and proteins interact differ-
ently with uranyl ions; such that DNA, unlike proteins, is
poorly visible on negatively stained grids at 25 Å reso-
lution. Consistently, our EM map displays a clear groove
in the density that correlates well with the path of DNA in
our docking model (Supplementary Figure S7). Moreover,
superposing the POLRMT elongation complex on
the POLRMT molecule in our docking model
(Supplementary Figure S7B) reveals the exit point for
the DNA downstream of the active site, which is also con-
sistent with the presence of a second groove in the density
in our EM map (Supplementary Figure S7C). Thus, the
Figure 5. Localization of the components of the transcription initiation
complex. (A) Surface representation of the EM map for POLRMT
apoenzyme. The flexibly fitted crystal structure (PDB ID: 3SPA) is
shown superimposed (cross-correlation coefficient 0.86) in cartoon rep-
resentation with a 90 rotation. (B) SAXS/WAXS model of TFB2M.
Surface representation (gray) of a filtered average bead model that de-
scribes the data (2=1.59). Shown inside the surface is the X-ray crys-
tallographic structure of TFB1M (PDB: 4GC5). (C) The experimental
and theoretical scattering profiles of TFB2M and TFB1M. The
observed scattering profile for TFB2M is well fit by the calculated
profile derived from the TBF1M crystal structure (2=1.68).
(D) EM and SAXS data reveal the relative positions of POLRMT
and TB2M within the complex. The EM envelope for the full
complex is shown as a gray mesh. The POLRMT EM map and
TFB2M SAXS model have been positioned within the EM envelope
and are shown in green and orange, respectively. (E) Relative orienta-
tion of the three protein components of the initiation complex (PDB
IDs: 3SPA, 4GC5 and 3TQ6). The EM envelope for the full complex is
shown as grey mesh, whereas POLRMT, TFAM and TFB2M are
shown as ribbons colored green, purple and orange, respectively. The
asterisk indicates additional volume corresponding to the N-terminal
region of POLRMT that was not resolved in the crystal structure.
Figure 6. Model of the intact mitochondrial transcription initiation
machinery. The EM envelope for the full complex is shown as a grey
mesh, while POLRMT, TFAM, TFB2M and the promoter DNA are
shown as ribbons colored green, purple, orange and blue, respectively.
The asterisk indicates additional volume corresponding to the
N-terminal region of POLRMT that was not resolved in the crystal
structure.
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features in our map appear to be consistent with the
expected location of the DNA according to our model.
DISCUSSION
In this study, we have performed the first structural char-
acterization of the human mitochondrial transcription
initiation machinery by combining biochemical, biophys-
ical and structural data. Using negative staining EM,
we determined the overall shape of the transcription initi-
ation complex, and, taking into account existing and
newly obtained biochemical data about the interactions
between different initiation components, we established
their placement within the EM envelope.
Our results suggest that the structural architecture
of the mitochondrial transcription initiation complex is
compact and does not follow a linear arrangement.
Instead, the initiation proteins are organized around the
promoter DNA forming a bi-lobed shape and are thus
likely to establish at least transient physical contacts
with one another. To establish which of these contacts
are important for stabilization of the initiation complex,
we examined all possible pairwise interactions between
the initiation proteins and we found that under our experi-
mental conditions, only the interaction between
POLRMT and TFAM is strong enough to be detected
and characterized by a highly sensitive method such as
ITC. We further demonstrate that the non-conserved N-
terminus of POLRMT and the C-terminal tail of TFAM
mediate this interaction, which is consistent with the fact
that both regions are essential for promoter-dependent
initiation (10,26). Moreover, our results are indirectly
corroborated by the fact that the yeast TFAM homolog,
Abf2, which does not interact with the polymerase, lacks
the C-terminal domain that we have identified to be
responsible for the interaction of human TFAM with
POLRMT (52)
Interestingly, although TFB2M is known to be indis-
pensable for initiation of transcription (53), was shown
to co-purify with POLRMT (22) and was suggested to
interact with the C-terminal tail of TFAM (54), our data
suggest that no biologically relevant amounts of pre-
assembled initiation complex or binary TFAM–TFB2M
or POLRMT–TFB2M complexes can exist in the
absence of the promoter DNA. Thus, the promoter
DNA segment likely serves as the main scaffold holding
all components of the initiation complex together, whereas
the interaction between TFAM and POLRMT acts as an
additional stabilizing factor. In our opinion, this hypoth-
esis reconciles our findings with earlier observations
(23,52). It is important to note that in order to facilitate
our structural studies, our purification protocols aimed
to quantitatively eliminate any nucleic acid contaminants
from the protein sample. It is possible that small traces of
DNA could have facilitated co-purification or
immunocoprecipitation of the initiation factors. It is also
possible that, in the presence of DNA, those interactions
might be bona fide protein–protein interactions, perhaps as
a consequence of DNA-induced or other conformational
changes. In this respect, the C-terminus of TFAM has
been shown to be a site of post-translational modifications
(55) and any such modifications are likely to affect the
nature of the interactions between the components of
the initiation complex.
The idea that TFAM physically associates with other
components of the initiation machinery had been
proposed earlier (50,52), but that model was based on
the assumption that POLRMT and TFB2M associate to
the promoter via an interaction between TFB2M and
TFAM. It is important to note, however, that the rela-
tively low affinity of the POLRMT–TFAM interaction
strongly suggests that a POLRMT–TFAM complex does
not exist outside of the context of initiation.
We were able to generate an EM-based model of
the transcription initiation complex, where previously
determined X-ray crystallographic structures of the con-
stituent components were docked into the bi-lobed EM
envelope and their positions further refined by taking
into account their binding sites on the LSP-containing
DNA. According to the model we obtained, the larger
lobe is occupied by POLMRT and TFB2M, which
bracket the promoter DNA on opposite sides, whereas
TFAM occupies the smaller lobe upstream of the initi-
ation site. Previously, TFAM was shown to substantially
bend the promoter DNA and its interaction with DNA
was thoroughly characterized using X-ray crystallography
(24,56). Both the ability of TFAM to bend DNA and its
interaction with the N-terminus of POLRMT seem to play
a critical role in establishing the compact organization of
the initiation complex. In fact, in our EM complex, the
N-terminus of POLRMT appears to be at least partially
ordered, further supporting its role in mediating an inter-
action during initiation. Deletion of the N-terminus of
POLRMT decouples it from TFAM, explaining why this
mutant is unable to initiate transcription (10).
The recent structure of the elongation complex of
POLRMT provides the first glimpse of the interaction
between the RNA polymerase and its DNA and RNA
substrates (46). An overlay of this structure with our
model of the transcription initiation complex further
supports the notion that TFB2M is in a position to bind
the DNA substrate near the active site [Supplementary
Figure S7 (21)]. It is important to note, however, that it
is not possible to ascertain whether the conformations
observed in the elongation complex are relevant in the
context of initiation, where TFAM and TFB2M likely
impose additional structural constraints. In fact, our EM
model is consistent with a shift in the position of the
upstream duplex [similar to that observed for T7 RNA
polymerase (57)] suggesting that a distinct elongation
mode is adopted upon dissociation of TFAM and
TFB2M.
The observed arrangement of initiation complex is fully
consistent with earlier cross-linking studies that revealed
that both POLRMT and TFB2M interact with the
promoter DNA (21). Our structure implies that the
methyltransferase fold of TFB2M interacts predominantly
with the single-stranded non-transcribed strand, consist-
ent with its expected binding mode (47). Moreover,
our model also suggests that the large N-terminal tail of
TFB2M interacts with the upstream duplex, which is
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again consistent with cross-linking studies (21).
Importantly, one aspect that provides additional valid-
ation of our EM structure is the fact that the docking is
in good agreement with the known position of TFAM-
binding relatively to the initiation site (21).
Although our study clarifies the mechanism by which
TFAM participates in transcription initiation, it does not
explain why, unlike in yeast, TFAM is necessary for this
process in mammalian mitochondria. This might be
related to the fact that mammalian mitochondrial pro-
moters have a more variable consensus sequence than
yeast (58,59), and thus TFAM might provide additional
selectivity to the DNA recognition process. Moreover,
TFAM has been shown to differentially regulate the
human mitochondrial promoters (60), implying that
relying on TFAM for initiation might provide an add-
itional opportunity for transcriptional regulation. This
also suggests that promoter-specific differences might
exist in the organization of the mitochondrial initiation
complex. Clearly, TFAM is needed for efficient transcrip-
tion from LSP and HSP1, however, that fact does
not imply that a two-component initiation complex
(TFB2M–POLRMT) is not capable of transcription initi-
ation (29). Moreover, transcription from HSP2 appears to
take place in the absence of TFAM (60,61).
Furthermore, even the participation of TFB2M is not
absolutely necessary for transcription initiation in vivo,
because POLRMT alone is capable of transcription initi-
ation for lagging DNA strand replication (33). These,
as well as other observations imply that the TFAM–
TFB2–POLRMT ensemble represents a flexible and
multipurpose machine that, depending on the circum-
stances, is capable of transcription initiation from
diverse sites. Such flexibility may facilitate regulation of
mitochondrial replication and transcription. Nevertheless,
at least in the context of LSP initiation, the data in this
manuscript strongly indicate that the POLRMT–TFAM
interaction is critical for assembly of the initiation
complex at LSP and likely important for its stabilization.
Based on these results, we favor a model where TFAM
helps recruit POLRMT to LSP through this interaction.
Furthermore, considering our structural model, it is likely
that the POLRMT–TFAM interaction introduces an add-
itional structural restraint that modulates the position of
the upstream duplex with respect to POLRMT. Thus,
release of the POLRMT–TFAM interaction after poly-
merization by POLRMT might be the event that deter-
mines the transition to elongation mode.
In summary, we have presented the first structural char-
acterization of the complete human mitochondrial initi-
ation complex and provided evidence that formation of
this complex depends critically on the promoter
DNA but is aided by a low-affinity interaction between
POLRMT and TFAM. Our EM model for transcrip-
tion initiation is consistent with previous experimental
evidence, and reveals the compact arrangement of
POLRMT, TFB2M and TFAM around the LSP. In
addition to shedding light on the nature of mitochondrial
transcription complexes, this will serve as the basis for
elucidation of the many structural and functional ques-
tions that still remain unanswered.
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